General Atlantic Leads $300M Series D Growth Round in Biofourmis
April 26, 2022
Biofourmis, a virtual care and digital medicine company headquartered in Needham/Boston, raised $300 million in a Series D growth round led by General Atlantic, with participation from CVS Health and existing investors including SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. The capital will be used to scale Biofourmis’ Care@Home virtual care platform, expand virtual specialty care and digital therapeutics programs, and accelerate clinical trials and partnerships in value-based care.
- Buyers
- General Atlantic, CVS Health, SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital, EDBI
- Targets
- Biofourmis
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.